Trial Details
TERMINATEDBasic Information
| Clinical ID | c1970 |
|---|---|
| Identifier | NCT04173273 |
| Trial Title | A Study Evaluating the Efficacy and Safety of Oral Etrasimod in the Treatment of Adult Participants With Moderately to Severely Active Crohn's Disease |
| Trial URL | Visit Original Page |
Study Information
| Study Results | NO |
|---|---|
| Conditions | Crohn's Disease |
| Interventions | DRUG: Etrasimod|DRUG: Etrasimod|DRUG: Placebo |
Participant Information
| Sponsor | Pfizer |
|---|---|
| City | Dothan |
| Country/Region | United States |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | ADULT, OLDER_ADULT |
Study Design
| Study Type | INTERVENTIONAL |
|---|---|
| Phase | PHASE3 |
Time Information
| Start Date | 2020-01-06 |
|---|---|
| Primary Completion Date | 2025-04-23 |
| Completion Date | 2025-06-09 |